Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
44.50
+0.41 (0.93%)
Nov 21, 2024, 3:14 PM EST - Market open
Amphastar Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 157.72 | 137.55 | 91.39 | 62.12 | 1.4 | 48.94 | Upgrade
|
| Depreciation & Amortization | 56.33 | 41.78 | 28.28 | 26.53 | 25.18 | 21.12 | Upgrade
|
| Other Amortization | 8.22 | 11.4 | 0.47 | 0.22 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.11 | 0.48 | 0.14 | -13.24 | 0.24 | 1.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 2.7 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 7.85 | 5.33 | -2.2 | 0.03 | -2.17 | - | Upgrade
|
| Loss (Gain) on Equity Investments | 1.08 | 1.98 | 1.18 | 0.21 | - | - | Upgrade
|
| Stock-Based Compensation | 23.36 | 20.24 | 17.86 | 18.69 | 20.5 | 17.3 | Upgrade
|
| Other Operating Activities | -13.74 | -13.74 | -15.75 | 5.39 | 0.82 | 5.12 | Upgrade
|
| Change in Accounts Receivable | -20.49 | -26.09 | -10.13 | -14.92 | -20.16 | 6.7 | Upgrade
|
| Change in Inventory | -19.52 | -1.72 | -11.75 | 1.26 | 15.3 | -41.1 | Upgrade
|
| Change in Accounts Payable | 58.06 | 13.24 | -0.74 | 3.63 | 20.09 | -11.72 | Upgrade
|
| Change in Income Taxes | -33.65 | -3.32 | -4.56 | 8.35 | -0.97 | 0.59 | Upgrade
|
| Change in Other Net Operating Assets | -17.11 | -6.32 | -5.01 | -0.27 | -2.95 | -6.22 | Upgrade
|
| Operating Cash Flow | 208.23 | 183.5 | 89.18 | 97.99 | 57.27 | 41.76 | Upgrade
|
| Operating Cash Flow Growth | 19.08% | 105.76% | -8.99% | 71.12% | 37.12% | 9.35% | Upgrade
|
| Capital Expenditures | -38.07 | -38.17 | -24.03 | -27.46 | -33.86 | -41.56 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.42 | - | - | - | Upgrade
|
| Cash Acquisitions | -129 | -506.41 | - | - | - | - | Upgrade
|
| Investment in Securities | -20.9 | -105.93 | -7.79 | 1.4 | -1.15 | -8.82 | Upgrade
|
| Other Investing Activities | -4.33 | 1.39 | -1.37 | -2.61 | -1.41 | -0.16 | Upgrade
|
| Investing Cash Flow | -192.3 | -649.12 | -32.78 | -28.67 | -36.42 | -50.53 | Upgrade
|
| Long-Term Debt Issued | - | 845 | - | 70 | 7.52 | 3.57 | Upgrade
|
| Long-Term Debt Repaid | - | -318.66 | -1.78 | -37.9 | -8.4 | -6.78 | Upgrade
|
| Total Debt Repaid | -58.3 | -318.66 | -1.78 | -37.9 | -8.4 | -6.78 | Upgrade
|
| Net Debt Issued (Repaid) | -44.74 | 526.34 | -1.78 | 32.1 | -0.88 | -3.21 | Upgrade
|
| Issuance of Common Stock | 3.56 | 10.97 | 15.66 | 15.93 | 23.17 | 3.42 | Upgrade
|
| Repurchase of Common Stock | -51.69 | -58.14 | -39.91 | -28.87 | -24.43 | -22.29 | Upgrade
|
| Other Financing Activities | -1.33 | -25.08 | -0.41 | -56.17 | -0.11 | 18.3 | Upgrade
|
| Financing Cash Flow | -94.19 | 454.09 | -26.44 | -37.02 | -2.25 | -3.78 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.42 | -0.28 | -0.22 | -0.22 | 0.35 | -0.1 | Upgrade
|
| Net Cash Flow | -78.69 | -11.8 | 29.75 | 32.08 | 18.96 | -12.65 | Upgrade
|
| Free Cash Flow | 170.15 | 145.34 | 65.15 | 70.54 | 23.41 | 0.21 | Upgrade
|
| Free Cash Flow Growth | 21.69% | 123.09% | -7.64% | 201.30% | 11209.66% | - | Upgrade
|
| Free Cash Flow Margin | 23.52% | 22.55% | 13.06% | 16.11% | 6.69% | 0.06% | Upgrade
|
| Free Cash Flow Per Share | 3.24 | 2.74 | 1.24 | 1.42 | 0.48 | 0.00 | Upgrade
|
| Cash Interest Paid | 27.86 | 17.57 | 3.02 | 2.11 | 2.2 | 2.44 | Upgrade
|
| Cash Income Tax Paid | 75.87 | 49 | 44.44 | 8.1 | 3.41 | 5.72 | Upgrade
|
| Levered Free Cash Flow | 8.61 | 245.1 | 57.67 | 56.9 | 33.28 | -51.46 | Upgrade
|
| Unlevered Free Cash Flow | 23.93 | 250.67 | 58.36 | 57.23 | 33.51 | -51.38 | Upgrade
|
| Change in Net Working Capital | 151.59 | -102.02 | 30.92 | 5.34 | -13.31 | 48.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.